Policing AIDS research

April 1991
New Scientist;4/27/91, Vol. 130 Issue 1766, p15
Argues that the World Health Organization is the agency which should administer ethical rules regarding AIDS drug trials. Need for one worldwide set of ethical standards; Alarm of many scientists over some clinical trials; More.


Related Articles

  • Drug trail double standards. Shah, Sonia // New Scientist;11/18/2006, Vol. 192 Issue 2578, p22 

    The article discusses why people who volunteer for clinical trials in the developing world do not get the same safeguards as those in the west. Drug companies export the last phases of clinical trials to developing countries. While the World Health Organization recognizes this to be a public...

  • Ethical review reporting of Chinese trials records in WHO primary registries. Liu Xuemei; Li Youping; Song Shangqi; Yin Senlin; Williams, Shawna // Journal of Medical Ethics;Mar2011, Vol. 37 Issue 3, p144 

    Objective To investigate the report rate of ethical review in registered Chinese trials records. Methods Chinese trials recorded in WHO primary registries and http://clinicaltrials.gov to 14 July 2009 were identified. The report rates of ethical review and each of the 20 items in WHO's Trial...

  • No delayed disclosure for registration of clinical trials. Fleck, Fiona // Bulletin of the World Health Organization;Jun2006, Vol. 84 Issue 6, p430 

    The article reports that the World Health Organization has introduced disclosure rules for pharmaceutical companies and research institutions to make clinical trials more transparent and publicly accountable. They will have to submit 20 key details when they register clinical trials with human...

  • Ethics and health.  // World Health;Sep/Oct95, Vol. 48 Issue 5, p9 

    Reports on a convention by the World Health Organization (WHO) in Geneva, Switzerland on August 1 to September 1995 to address issues concerning health and ethics. Variety of health professionals from developing and Western countries participating in the convention; Questions affecting health...

  • WHO grants public access to VigiBase via VigiAccess interface.  // Reactions Weekly;May2015, Vol. 1550 Issue 1, p6 

    The article reviews the VigiAccess located at www.vigiaccess.org that allows individuals to search VigiBase, which contains more than 10 million reports on medicines and vaccines dating back to 1968 from World Health Organization (WHO).

  • From bench to bedside and back again?  // CMAJ: Canadian Medical Association Journal;6/8/2004, Vol. 170 Issue 12, p1765 

    Comments on the concept of studying a small subset of patients in line with a clinical study involving nine patients with non-small-cell lung cancer who responded to the drug gefitinib. Information on gefitinib, a chemotherapeutic agent; Impact of the concept on large, population-based...

  • PARTAKE Survey of Public Knowledge and Perceptions of Clinical Research in India. Burt, Tal; Dhillon, Savita; Sharma, Pooja; Khan, Danish; MV, Deepa; Alam, Sazid; Jain, Sarika; Alapati, Bhavana; Mittal, Sanjay; Singh, Padam // PLoS ONE;Jul2013, Vol. 8 Issue 7, p1 

    Background: A public that is an informed partner in clinical research is important for ethical, methodological, and operational reasons. There are indications that the public is unaware or misinformed, and not sufficiently engaged in clinical research but studies on the topic are lacking....

  • Adverse events monitoring as a routine component of vaccine clinical trials: Evidence from the... Mayans, Marti Vall; Robertson, Susan E. // Bulletin of the World Health Organization;2000, Vol. 78 Issue 9, p1166 

    Reports on the use of the World Health Organization (WHO) Vaccine Trial Registry to assess whether and how investigators are monitoring adverse events following immunization (AEFI) in vaccine trials. Objective of the WHO Immunization Safety Priority; AEFI according to reports; Points for...

  • WHO Clinical trial registry platform: addition of China and India.  // Weekly Epidemiological Record;8/17/2007, Vol. 82 Issue 33, p303 

    The article reports on the expansion of the clinical trial registry platform of the World Health Organization (WHO), which is set to include trial registers from China and India. The move is a major step for policymakers and scientists because it will enable them to track local research...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics